SLC1A2 and amyotrophic lateral sclerosis: Ceftriaxone can increase the expression and biochemical and functional activity of EAAT2 in animal brains and play a neuroprotective role in animal disease models based on glutamate toxicity, such as ischemic brain injury, motor neuron degeneration, amyotrophic lateral sclerosis (ALS).123